Skip to main content
. 2022 Apr 14;9(7):ofac203. doi: 10.1093/ofid/ofac203

Table 5.

Comparison of Length of Sick Leave After COVID-19 Vaccination, SARS-CoV-2 Infection, and SARS-CoV-2 Quarantine

Median (IQR) No. Summary
Sick leave in vaccinees without a history of SARS-CoV-2 infection
 Potential sick leave in daysa
  After first vaccination 2 (1–3) n = 239 639
  After second vaccination 2 (1–3) n = 538c 1292
 Actual sick leave in daysb
  After first vaccination 1 (0–2) n = 239 333
  After second vaccination 1 (0–2) n = 538c 770
Sick leave in vaccinees with a history of SARS-CoV-2 infectiond
 Potential sick leave in daysa
  After first vaccination 2 (2–4) n = 41 138
  After second vaccination 2 (1.5–4) n = 24 65
 Actual sick leave in daysb
  After first vaccination 1 (1–2) n = 41 82
  After second vaccination 1 (0–2) n = 24 31
  Sick leave because of SARS-CoV-2 infection 14 (10–21)c n = 250 4642
  Sick leave because of SARS-CoV-2 quarantine 14 (10–14)c n = 352 4710

Abbreviations: COVID-19, coronavirus disease 2019; IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

a

Survey participants were asked how many days they would have been unable to go to work because of COVID-19 vaccination–associated adverse reactions if the vaccination day was followed by days off (weekend, holidays, etc.).

b

Survey participants were asked how many days they actually were on sick leave.

c

One implausible value recoded to missing.

d

SARS-CoV-2 infection may have occurred before, during, or after the vaccination process.

HHS Vulnerability Disclosure